Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Treatment of arterial hypertension in obese patients.

Wenzel UO, Benndorf R, Lange S.

Semin Nephrol. 2013 Jan;33(1):66-74. doi: 10.1016/j.semnephrol.2012.12.009. Review.

PMID:
23374895
2.

Management of arterial hypertension in obese patients.

Wenzel UO, Krebs C.

Curr Hypertens Rep. 2007 Dec;9(6):491-7. Review.

PMID:
18367013
3.

Treatment of arterial hypertension in obese patients.

Wenzel UO, Krebs C.

Contrib Nephrol. 2006;151:230-42. Review.

PMID:
16929146
4.

[Hypertension in obese patients: Pathophysiology and management].

Girerd X, Hansel B.

Presse Med. 2009 Apr;38(4):609-13. doi: 10.1016/j.lpm.2009.01.006. Epub 2009 Feb 23. Review. French.

PMID:
19233604
5.
6.
7.

Clinical role of direct renin inhibition in hypertension.

Taylor AA, Pool JL.

Am J Ther. 2012 May;19(3):204-10. doi: 10.1097/MJT.0b013e3182068da5.

PMID:
21317620
8.

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.

Volpe M, Tocci G.

Vasc Health Risk Manag. 2012;8:371-80. doi: 10.2147/VHRM.S28359. Epub 2012 Jun 11. Review.

9.

Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.

Contreras F, de la Parte MA, Cabrera J, Ospino N, Israili ZH, Velasco M.

Am J Ther. 2003 Nov-Dec;10(6):401-8. Review.

PMID:
14624277
10.

Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.

Doggrell SA.

Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):119-25. Review.

PMID:
15834464
11.

50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?

Brown A, Captain B.

Am J Ther. 2011 Nov;18(6):e244-54. doi: 10.1097/MJT.0b013e3181e90863. Review.

PMID:
21436766
12.

[Therapeutic options for metabolic syndrome in obese patients].

Carella AM, Conte M.

Clin Ter. 2007 Sep-Oct;158(5):457-64. Review. Italian.

PMID:
18062354
13.

Is there a rationale for angiotensin blockade in the management of obesity hypertension?

Sharma AM.

Hypertension. 2004 Jul;44(1):12-9. Epub 2004 Jun 1. Review.

14.

Thiazide and loop diuretics.

Sica DA, Carter B, Cushman W, Hamm L.

J Clin Hypertens (Greenwich). 2011 Sep;13(9):639-43. doi: 10.1111/j.1751-7176.2011.00512.x. Epub 2011 Jul 27. Review.

15.

Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors.

Berne C, Pollare T, Lithell H.

Diabetes Care. 1991 Nov;14 Suppl 4:39-47. Review.

PMID:
1748056
16.

Secondary hypertension: obesity and the metabolic syndrome.

Singer GM, Setaro JF.

J Clin Hypertens (Greenwich). 2008 Jul;10(7):567-74. Review.

17.
18.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
19.

Optimizing blood pressure control in the obese patient.

Pischon T, Sharma AM.

Curr Hypertens Rep. 2002 Oct;4(5):358-62. Review.

PMID:
12217253
20.

Fixed-dose combination therapy in hypertension: pros.

Taddei S.

High Blood Press Cardiovasc Prev. 2012 Jun 1;19(2):55-7. doi: 10.2165/11632180-000000000-00000.

PMID:
22867090
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk